Haemolytic uraemic syndrome and E coli 0157: Prevention rests with sound public health measures

BMJ

Volumn 318, Issue 7185, 1999, Pages 684-685

  Fitzpatrick, Margaret ^a  

^a University Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGOSACCHARIDE; TOXOID; VEROTOXIN;

EDITORIAL; ESCHERICHIA COLI O157; FECES CULTURE; FOOD CONTAMINATION; FOOD IRRADIATION; GRAM NEGATIVE INFECTION; HEALTH EDUCATION; HEMOLYTIC UREMIC SYNDROME; HUMAN; INFECTION CONTROL; INTESTINE; PRIORITY JOURNAL; PROGNOSIS; PUBLIC HEALTH;

BACTERIAL TOXINS; ESCHERICHIA COLI O157; HEMOLYTIC-UREMIC SYNDROME; HUMANS; PUBLIC HEALTH; RISK FACTORS; SHIGA-LIKE TOXIN I;

EID: 0033550894     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.318.7185.684     Document Type: Editorial

References (10)

1. Milford DV, Taylor CM, Gulleridge B, Hall SM, Rowe B, Kleanthous H Haemolytic uraemic syndromes in the British Isles, 1985–8: association with verocytotoxin producing Escherichia coli. Part 1: clinical and epidemiological aspects. Arch Dis Child 1990; 65: 716–721.
2. Kleanthous H, Smith HR, Scotland SM, Gross RJ, Rowe B, Taylor CM, et al Haemolytic uraemic syndromes in the British Isles, 1985–8: association with verocytotoxin producing Escherichia coli. Part 2: microbiological aspects. Arch Dis Child 1990; 65: 722–727.
3. Coad NAG, Marshall T, Rowe B, Taylor CM Changes in the post-enteropathic form of the haemolytic uraemic syndrome in children. Clin Nephrol 1991; 35: 10–16.
4. Fitzpatrick MM, Shah VS, Trompeter RS, Dillon MJ, Barratt TM Long term renal outcome of childhood haemolytic uraemic syndrome. BMJ 1991; 303: 489–492.
5. Rowe PC, Orrbine E, Lior H, Wells GA, Yetisir E, Clulow M, et al Risk of hemolytic uremic syndrome after sporadic Escherichia coli 0157:H7 infection: results of a Canadian collaborative study. J Pediatr 1998; 132: 777–782.
6. Thomas A, Chart H, Cheasty T, Smith HR, Frost JA, Rowe B Verocytotoxin-producing E coli, particularly serogroup 0157:H7 associated with human infections in the United Kingdom: 1989–91. Epidemiol Infect 1993; 110: 591–600.
7. Armstrong GD, Rowe PC, Goodyer P, Orrbine E, Klassen TP, Wells G, et al A phase 1 study of chemically synthesized verotoxin (Shiga-like toxin) Pk-trisaccharide receptors attached to chromosorb for preventing hemolytic uremic syndrome. J Infect Dis 1995; 171: 1042–1045.
8. Taylor CM, Monnens LAH Advances in haemolytic uraemic syndrome. Arch Dis Child 1998; 78: 190–193.
9. Brotman M, Giannella RA, Alm PF, Bauman M, Bennett AR, Black RE, et al Consensus Conference statement: E coli 0157:H7 infections—an emerging national health crisis. July 11–13, 1994. Gastroenterology 1995; 108: 1923–1934.
10. Acheson DW, Levine MM, Kaper JB, Keusch GT Protective immunity to Shiga-like toxin I following oral immunization with Shiga-like toxin I-subunit-producing Vibrio cholerae CVD 103-HgR. Infect Immun 1996; 64: 355–357.